Black Rock Inc. Onconova Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Onconova Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 248,878 shares of ONTX stock, worth $146,838. This represents 0.0% of its overall portfolio holdings.
Number of Shares
248,878
Previous 248,878
-0.0%
Holding current value
$146,838
Previous $251,000
41.83%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ONTX
# of Institutions
25Shares Held
2.86MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.05MShares$616,7030.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA707KShares$417,0830.0% of portfolio
-
Geode Capital Management, LLC Boston, MA224KShares$132,2100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny218KShares$128,6750.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il121KShares$71,3960.0% of portfolio
About Onconova Therapeutics, Inc.
- Ticker ONTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,895,600
- Market Cap $12.3M
- Description
- Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...